This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Rosemary oil

Single 6-month RCT (Panahi 2015) showed non-inferiority to 2% minoxidil for MPB hair count.

Aliases (3)

Rosmarinus officinalis essential oil · rosemary EO · rosemary leaf extract

TYPICAL DOSE

—

ROUTE

—

CYCLE

—

STORAGE

—

Overview

What is Rosemary oil?

Single 6-month RCT (Panahi 2015) showed non-inferiority to 2% minoxidil for MPB hair count. Very low risk. Worth knowing as botanical alternative or adjunct.

What to Expect

Week 1
Tolerability and dose-response.
Week 2-4
Early effect window.
Week 4-8
Peak benefit assessment.
Week 8+
Cycle decision point.

Was this helpful?

Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

✎

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load ▸

Loading…

Continue: Extended research →

Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Rosemary oil

ATP-sensitive K+ channel opener / vasodilator (cardiovascular drug repurposed for hair growth)

Imidazole antifungal. Topical (1% OTC, 2% Rx) and oral (Rx, restricted post-2013 FDA warning for hepatotoxicity).